Status:

UNKNOWN

TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas

Lead Sponsor:

Tiburio Therapeutics

Conditions:

Non-Functional Pituitary Adenoma

Pituitary Tumor, Nonfunctioning

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

This is a randomized, double-blind, placebo-controlled study to assess the safety, tolerability, efficacy, PK, and PD of the chimeric dopamine-somatostatin receptor agonist, TBR-760, in adult patients...

Detailed Description

This is a randomized, double-blind, placebo-controlled study to assess the safety, tolerability, efficacy, PK, and PD of the chimeric dopamine-somatostatin receptor agonist, TBR-760, in adult patients...

Eligibility Criteria

Inclusion

  • Key
  • Confirmed diagnosis of NFPA (defined as lack of clinical and biochemical evidence of adenohypophyseal hormone excess), and be status-post one TSS with a NFPA remnant of ≥ 10mm (maximum diameter)
  • Study subjects must be capable of giving informed consent and reading and signing the informed consent form after the nature of the study has been fully explained by the Investigator or Investigator designee
  • Study subject must be willing and able to complete all study assessments and procedures and to communicate effectively with the Investigator and site staff.
  • Key

Exclusion

  • Has undergone more than one TSS, or had TSS \<6 months prior to screening, or is anticipated to require TSS within 6 months of Screening
  • Has undergone radiation therapy to the head for any reason, or is already planned to have or anticipated to require radiation therapy during the study period;
  • Has any contraindications to magnetic resonance imaging including allergy or intolerance to gadolinium or gadolinium-based contrast;
  • In the opinion of the Investigator, the patient is unable to meet the requirements of the study.

Key Trial Info

Start Date :

May 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04335357

Start Date

May 1 2020

End Date

June 1 2023

Last Update

April 6 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.